Uma carreira médica dedicada ao tratamento dos pacientes com doenças do fígado, pâncreas e vesícula biliar — da UFRGS ao Toronto General Hospital.
Doutorado em andamento, Gastroenterologia e Hepatologia, Programa de Pós-Graduação da Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil
Mestrado em Cirurgia, Programa de Pós-Graduação, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil
Residência de Cirurgia do Aparelho Digestivo, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil
Residência de Cirurgia Geral, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil
Fellowship Clínico — Cirurgia Hepatobiliopancreática & Transplante de Órgãos Abdominais, University Health Network, Toronto General Hospital, Toronto, Canadá
Pesquisador Contratado — Cirurgia Hepatobiliopancreática & Transplante de Órgãos Abdominais, University Health Network, Toronto General Hospital, Toronto, Canadá
Faculdade de Medicina, formado com Láurea Acadêmica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil
Possui artigos publicados em todos os grandes periódicos do mundo na área de cirurgia, transplante hepático e hepatologia.
1. Solis-Pazmino P, Vasques L, Maldonado P, Lunardi JD, Schneider M, Gorgen A. Hidden lymphoma in the appendix: a case of primary appendiceal diffuse large B-cell lymphoma presenting as acute appendicitis. J Surg Case Rep. 2023 Jun 1;2023(6):rjad289.
2. Schlegel A, van Reeven M, Croome K, et al.; DCD Collaborator Group. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation. J Hepatol. 2022 Feb;76(2):371-382.
3. Ivanics T, Nelson W, Patel MS, Claasen MPAW, Lau L, Gorgen A, Abreu P, Goldenberg A, Erdman L, Sapisochin G. The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach. Liver Transpl. 2022 Apr;28(4):593-602.
4. Muaddi H, Abreu P, Ivanics T, Claasen M, Yoon P, Gorgen A, Al-Adra D, Badenoch A, McCluskey S, Ghanekar A, Reichman T, Sapisochin G. The effect of perioperative packed red blood cells transfusion on patient outcomes after liver transplant for hepatocellular carcinoma. HPB (Oxford). 2022 Mar;24(3):370-378.
5. Chen K, Gorgen A, Ding A, Du L, Jiang K, Ding Y, Sapisochin G, Ghanekar A. Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma. Hepatol Commun. 2021 Mar 11;5(7):1310-1328.
6. Lai Q, Sapisochin G, Gorgen A, et al. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant. JAMA Surg. 2021 Sep 1;156(9):e213112.
7. Gorgen A, Sapisochin G. Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume. Transplantation. 2021 Jun 1;105(6):e64.
8. Gorgen A, Sapisochin G. Reply to "Reducing the Safety Limit for Remnant Liver Volume in Living Donor Hepatectomy: Are We Pushing the Envelope Off the Edge?". Transplantation. 2021 Jun 1;105(6):e62.
9. Ivanics T, Salinas-Miranda E, Abreu P, Khalvati F, Namdar K, Dong X, Deniffel D, Gorgen A, Erdman L, Jhaveri K, Haider M, Veit-Haibach P, Sapisochin G. A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker. Transplantation. 2021 Nov 1;105(11):2435-2444.
10. Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, et al. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. JAMA Surg. 2021 Jun 1;156(6):559-567.
11. Zuckerman J, Gorgen A, Acuna SA, Abreu P, Goldaracena N, Galvin Z, Cattral MS, Ghanekar A, McGilvray ID, Lilly LB, Selzner N, Grant DR, Sapisochin G. Outcomes of Highly Selected Live Donors With a Future Liver Remnant Less Than or Equal to 30%: A Matched Cohort Study. Transplantation. 2021 Nov 1;105(11):2397-2403.
12. Gorgen A, Ivanics T, Sapisochin G. Liver transplantation for unresectable colorectal metastasis: a new hope. Hepatobiliary Surg Nutr. 2020 Oct;9(5):665-668.
13. Abreu P, Gorgen A, Oldani G, Hibi T, Sapisochin G. Recent advances in liver transplantation for cancer: The future of transplant oncology. JHEP Rep. 2019 Jul 30;1(5):377-391.
14. Gorgen A, Galvin Z, Huang AC, et al. The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study. Transplantation. 2020 Oct;104(10):2087-2096.
15. Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM. Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival. Transplantation. 2020 Oct;104(10):2105-2112.
16. Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020 Feb;72(2):364-377.
17. Gorgen A, Sapisochin G. Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone? Ann Surg. 2021 Jul 1;274(1):e101.
18. Firl DJ, Sasaki K, Agopian VG, Gorgen A, et al.; European Hepatocellular Cancer Liver Transplant Study Group. Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients. Hepatology. 2020 Feb;71(2):569-582.
19. Gorgen A, Rosales R, Sadler E, Beecroft R, Knox J, Dawson LA, Ghanekar A, Grant D, Greig PD, Sapisochin G. Patterns and Predictors of Mortality After Waitlist Dropout of Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. Transplantation. 2019 Oct;103(10):2136-2143.
20. Goldaracena N, Gorgen A, Doyle A, et al. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. J Hepatol. 2019 Apr;70(4):666-673.
21. Doyle A, Gorgen A, Muaddi H, et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients. J Hepatol. 2019 May;70(5):866-873.
22. Gorgen A, Prediger C, Prediger JE, Chedid MF, Backes AN, de Araujo A, Grezzana-Filho TJM, Leipnitz I, Chedid AD, Alvares-da-Silva MR, Sapisochin G, Kruel CRP. Serum Factor V Is a Continuous Biomarker of Graft Dysfunction and a Predictor of Graft Loss After Liver Transplantation. Transplantation. 2019 May;103(5):944-951.
23. Gorgen A, Goldaracena N, Zhang W, Sapisochin G. Intrahepatic cholangiocarcinoma, are we making progress? Hepatobiliary Surg Nutr. 2018 Apr;7(2):127-129.
24. Gorgen A, Muaddi H, Zhang W, McGilvray I, Gallinger S, Sapisochin G. The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases. Can J Gastroenterol Hepatol. 2018 Jan 10;2018:9531925.
25. Gorgen A, Goldaracena N, Zhang W, et al. Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World Experience. Semin Liver Dis. 2018 May;38(2):134-144.
26. Goldaracena N, Gorgen A, Sapisochin G. Reply. Liver Transpl. 2018 Mar;24(3):441.
27. Goldaracena N, Gorgen A, Sapisochin G. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl. 2018 Feb;24(2):294-303.